Katrien Deroost

Katrien Deroost

Auto-generated profile, based on publicly available information

Katrien Deroost

Fundação de Medicina Tropical Dr. Heitor Vieira Dourado (FMT-HVD), Manaus, Amazonas, Brazil

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 December 2015 in FEMS Microbiology Reviews
Verified
Journal Article
Closed access
PDF file
KDKatrien Deroost
Katrien Deroost
TPThao-Thy Pham
Thao-Thy Pham
Ghislain OpdenakkerGhislain Opdenakker
Ghislain Opdenakker
PSPhilippe E. Van den Steen
Philippe E. Van den Steen
Coevolution of humans and malaria parasites has generated an intricate balance between the immune system of the host and virulence factors of the parasite, equilibrating maximal parasite transmission with limited host damage. Focusing on the blood stage of the disease, we discuss how the balance between anti-parasite immunity versus immunomodulatory and evasion mechanisms of the parasite may result in parasite clearance or chronic infection without major symptoms, whereas imbalances characterized by excessive parasite growth, exaggerated immune reactions or a combination of both cause severe pathology and death, which is detrimental for both parasite and host. A thorough understanding of the immunological balance of malaria and its relation to other physiological balances in the body is of crucial importance for developing effective interventions to reduce malaria-related morbidity and to diminish fatal outcomes due to severe complications. Therefore, we discuss in this review the detailed mechanisms of anti-malarial immunity, parasite virulence factors including immune evasion mechanisms and pathogenesis. Furthermore, we propose a comprehensive classification of malaria complications according to the different types of imbalances.

1 May 2010 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
PSPhilippe E. Van den Steen
Philippe E. Van den Steen
NGNathalie Geurts
Nathalie Geurts
KDKatrien Deroost
Katrien Deroost
IAIlse Van Aelst
Ilse Van Aelst
SVSebastien Verhenne
Sebastien Verhenne
Ghislain OpdenakkerGhislain Opdenakker
Ghislain Opdenakker
Rationale: Malaria infection is often complicated by malaria-associated acute respiratory distress syndrome (MA-ARDS), characterized by pulmonary edema and hemorrhages. No efficient treatments are available for MA-ARDS and its pathogenesis remains poorly understood. Objectives: Development of a new animal model for MA-ARDS to explore the pathogenesis and possible treatments. Methods: C57BL/6 mice were infected with Plasmodium berghei NK65, and the development of MA-ARDS was evaluated by the analysis of lung weight, histopathology, and bronchoalveolar lavages. Cytokine and chemokine expression in the lungs was analyzed by reverse transcription-polymerase chain reaction, and the accumulation of leukocyte subclasses was determined by flow cytometric analysis. Measurements and Main Results: In this model, the pulmonary expression of several cytokines and chemokines was increased to a higher level than in mice infected with Plasmodium chabaudi AS, which does not cause MA-ARDS. By depletion experiments, CD8+ T lymphocytes were shown to be pathogenic. High doses of dexamethasone blocked MA-ARDS, even when administered after appearance of the complication, and reduced pulmonary leukocyte accumulation and the expression of a monocyte/macrophage-attracting chemokine. Conclusions: We developed a novel model of MA-ARDS with many similarities to human MA-ARDS and without cerebral complications. This contrasts with the more classical model with P. berghei ANKA, characterized by fulminant cerebral malaria. Hence, infection with P. berghei NK65 generates a broader time window to study the pathogenesis and to evaluate candidate treatments. The finding that high doses of dexamethasone cured MA-ARDS suggests that it might be more effective against MA-ARDS than it was in the clinical trials for cerebral malaria.

7 April 2008 in European Journal of Immunology
Verified
Journal Article
Open access
PDF file
PSPhilippe E. Van den Steen
Philippe E. Van den Steen
KDKatrien Deroost
Katrien Deroost
IAIlse Van Aelst
Ilse Van Aelst
NGNathalie Geurts
Nathalie Geurts
EMErik Martens
Erik Martens
Ghislain OpdenakkerGhislain Opdenakker
Ghislain Opdenakker
Cerebral malaria (CM) results from the binding of infected erythrocytes and leukocytes to brain endothelia. The precise mechanisms underlying lymphocyte recruitment and activation in CM remain unclear. Therefore, the expression of various chemokines was quantified in brains of mice infected with Plasmodium berghei ANKA (PbA). Several chemokines attracting monocytes and activated T‐lymphocytes were expressed at high levels. Their expression was almost completely abrogated in IFN‐γ ligand and receptor KO mice, indicating that IFN‐γ is an essential chemokine inducer in vivo. Surprisingly, the expression levels of chemokines, IFN‐γ and also adhesion molecules in the brain were not lower in CM‐resistant Balb/c and DBA/2 mice compared to CM‐sensitive C57BL/6 and DBA/1 mice, although T lymphocyte sequestration in the brain was significantly less in CM‐resistant than in CM‐sensitive mice. This difference correlated with a higher up‐regulation of the CXC chemokine receptor (CXCR)‐3 on splenic T cells and a higher chemotactic response to IFN‐γ‐inducible protein‐10 (IP‐10) in C57BL/6 compared to Balb/c mice. In conclusion, parasite‐induced IFN‐γ in the brain results in high local expression levels of specific chemokines for monocytes and lymphocytes. The strain‐dependent susceptibility to develop CM is more related to the expression of CXCR3 in circulating leukocytes than to the chemokine expression levels in the brain.

1 July 2013 in Trends in Parasitology
Verified
Journal Article
Closed access
PSPhilippe E. Van den Steen
Philippe E. Van den Steen
KDKatrien Deroost
Katrien Deroost
JDJulie Deckers
Julie Deckers
EHEvelien Van Herck
Evelien Van Herck
SSSofie Struyf
Sofie Struyf
Ghislain OpdenakkerGhislain Opdenakker
Ghislain Opdenakker

1 May 2013 in American Journal of Respiratory Cell and Molecular Biology
Verified
Journal Article
Closed access
KDKatrien Deroost
Katrien Deroost
ATAriane Tyberghein
Ariane Tyberghein
NLNatacha Lays
Natacha Lays
SNSam Noppen
Sam Noppen
ESEvelin Schwarzer
Evelin Schwarzer
PSPhilippe E. Van den Steen
Philippe E. Van den Steen
Malaria-associated acute respiratory distress syndrome (MA-ARDS) is a deadly complication of malaria, and its pathophysiology is insufficiently understood. Both in humans and in murine models, MA-ARDS is characterized by marked pulmonary inflammation. We investigated the role of hemozoin in MA-ARDS in C57Bl/6 mice infected with Plasmodium berghei NK65, P. berghei ANKA, and P. chabaudi AS. By quantifying hemozoin in the lungs and measuring the disease parameters of MA-ARDS, we demonstrated a highly significant correlation between pulmonary hemozoin concentrations, lung weights, and alveolar edema. Histological analysis of the lungs demonstrated that hemozoin is localized in phagocytes and infected erythrocytes, and only occasionally in granulocytes. Species-specific differences in hemozoin production, as measured among individual schizonts, were associated with variations in pulmonary pathogenicity. Furthermore, both pulmonary hemozoin and lung pathology were correlated with the number of infiltrating inflammatory cells, an increased pulmonary expression of cytokines, chemokines, and enzymes, and concentrations of alveolar vascular endothelial growth factor. The causal relationship between hemozoin and inflammation was investigated by injecting P. falciparum–derived hemozoin intravenously into malaria-free mice. Hemozoin potently induced the pulmonary expression of proinflammatory chemokines (interferon-γ inducible protein–10/CXC-chemokine ligand (CXCL)10, monocyte chemotactic protein–1/CC-chemokine ligand 2, and keratinocyte-derived chemokine/CXCL1), cytokines (IL-1β, IL-6, IL-10, TNF, and transforming growth factor–β), and other inflammatory mediators (inducible nitric oxide synthase, heme oxygenase–1, nicotinamide adenine dinucleotide phosphate– oxidase–2, and intercellular adhesion molecule–1). Thus, hemozoin correlates with MA-ARDS and induces pulmonary inflammation.

6 April 2017 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
BBBarbara Baro
Barbara Baro
KDKatrien Deroost
Katrien Deroost
TRTainá Raiol
Tainá Raiol
MBMarcelo Brito
Marcelo Brito
AAAnne C. G. Almeida
Anne C. G. Almeida
HPHernando Del Portillo
Hernando Del Portillo
Plasmodium vivax is the most widely distributed human malaria parasite and responsible for large amounts of disease and burden [1]. The presence of P. vivax in the bone marrow was first noticed in the late 19th century [2], and examinations of sternal bone marrow aspirates were performed as an accessory to examinations of peripheral blood in malaria, including P. vivax [3]. Since then, little progress has been made in studying P. vivax infections in this tissue. One report explored accumulation of dyserythropoietic cells in anaemic infected patients [4]. In addition, two case studies reported P. vivax infections after autologous bone marrow transplantation [5][6], and a third one documented an accidental P. vivax infection due to bone marrow transplantation between a malaria-infected donor and a malaria-free receptor [7]. In Brazil, one patient with persistent thrombocytopaenia and an enlarged spleen was diagnosed with chronic P. vivax malaria after the finding of schizonts in the bone marrow aspirate [8]. In all these reports and case studies, however, parasite loads and life stages found in the bone marrow were not investigated, and no molecular tools were available to rule out mixed infections or to characterize specific parasite stages